HuGE Literature Finder
Records
1
-
26
| A Higher Polygenic Risk Score Is Associated with a Higher Recurrence Rate of Atrial Fibrillation in Direct Current Cardioversion-Treated Patients. Medicina (Kaunas, Lithuania) 2021 11 57 (11): . Vogel Simon, Rudaka Irina, Rots Dmitrijs, Isakova Jekater?na, Kal?js Oskars, V?ksne Krist?ne, Gail?te Lin |
| Genetic variants associated with atrial fibrillationand long-term recurrence after catheter ablation for atrialfibrillation in Turkish patients. Anatolian journal of cardiology 2021 02 25 (2): 129-138. Ulus Taner, Dural Muhammet, Me?e Pelin, Yetmi? Furkan, Mert Kadir U?ur, Görenek Bülent, Çilingir O?uz, Erzurumluoglu Gökalp Ebru, Arslan Serap, Artan Sevilhan, Aykaç Özlem, Çolak Ertu?rul, Yorgun Hikmet, Canpolat U?ur, Aytemir Kudr |
| Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review. Breast cancer research : BCR 2020 2 22 (1): 13. de Ruijter Tim C, van der Heide Frank, Smits Kim M, Aarts Maureen J, van Engeland Manon, Heijnen Vivianne C |
| Association between gene variants and the recurrence of atrial fibrillation: An updated meta-analysis. Medicine 2019 Jun 98 (23): e15953. Jiang Tao, Wang Ya-Nan, Qu Qiang, Qi Ting-Ting, Chen Yun-Dai, Qu Ji |
| Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy. Breast care (Basel, Switzerland) 2019 2 13 (6): 425-433. Schmitt Manfred, Wilhelm Olaf G, Noske Aurelia, Schricker Gabriele, Napieralski Rudolph, Vetter Martina, Aubele Michaela, Perkins Jonathan, Lauber Jürgen, Ulm Kurt, Thomssen Christoph, Martens John W M, Weichert Wilko, Kiechle Mari |
| A Genetic Risk Score for Atrial Fibrillation Predicts the Response to Catheter Ablation. Korean circulation journal 2018 Dec . Choe Won Seok, Kang Jun Hyuk, Choi Eue Keun, Shin Seung Yong, Lubitz Steven A, Ellinor Patrick T, Oh Seil, Lim Hong E |
| Association of atrial fibrillation susceptibility genes, atrial fibrillation phenotypes and response to catheter ablation: a gene-based analysis of GWAS data. Journal of translational medicine 2017 Apr 15 (1): 71. Husser Daniela, Büttner Petra, Ueberham Laura, Dinov Borislav, Sommer Philipp, Arya Arash, Hindricks Gerhard, Bollmann Andre |
| PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma. Oncotarget 2016 10 7 (46): 75827-75838. Sailer Verena, Holmes Emily Eva, Gevensleben Heidrun, Goltz Diane, Dröge Freya, de Vos Luka, Franzen Alina, Schröck Friederike, Bootz Friedrich, Kristiansen Glen, Schröck Andreas, Dietrich Di |
| PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies. The Journal of molecular diagnostics : JMD 2016 12 19 (1): 107-114. Uhl Barbara, Gevensleben Heidrun, Tolkach Yuri, Sailer Verena, Majores Michael, Jung Maria, Meller Sebastian, Stein Johannes, Ellinger Jörg, Dietrich Dimo, Kristiansen Gl |
| PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy. Clinical epigenetics 2016 10 8 104. Holmes Emily Eva, Goltz Diane, Sailer Verena, Jung Maria, Meller Sebastian, Uhl Barbara, Dietrich Jörn, Röhler Magda, Ellinger Jörg, Kristiansen Glen, Dietrich Di |
| Common genetic variants and response to atrial fibrillation ablation. Circulation. Arrhythmia and electrophysiology 2015 Apr 8 (2): 296-302. Shoemaker M Benjamin, Bollmann Andreas, Lubitz Steven A, Ueberham Laura, Saini Harsimran, Montgomery Jay, Edwards Todd, Yoneda Zachary, Sinner Moritz F, Arya Arash, Sommer Philipp, Delaney Jessica, Goyal Sandeep K, Saavedra Pablo, Kanagasundram Arvindh, Whalen S Patrick, Roden Dan M, Hindricks Gerhard, Ellis Christopher R, Ellinor Patrick T, Darbar Dawood, Husser Danie |
| Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success. Journal of the American Heart Association 2015 4 (8): . Choi Eue-Keun, Park Jae Hyung, Lee Ji-Young, Nam Chung Mo, Hwang Min Ki, Uhm Jae-Sun, Joung Boyoung, Ko Young-Guk, Lee Moon-Hyoung, Lubitz Steven A, Ellinor Patrick T, Pak Hui-N |
| Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer. Epigenetics 2014 6 9 (8): 1138-48. Nawaz Imran, Qiu Xiaoming, Wu Heng, Li Yang, Fan Yaguang, Hu Li-Fu, Zhou Qinghua, Ernberg Ingem |
| Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer. Journal of cancer research and clinical oncology 2014 6 140 (11): 1849-61. Litovkin Kirill, Joniau Steven, Lerut Evelyne, Laenen Annouschka, Gevaert Olivier, Spahn Martin, Kneitz Burkhard, Isebaert Sofie, Haustermans Karin, Beullens Monique, Van Eynde Aleyde, Bollen Mathi |
| Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. Heart rhythm : the official journal of the Heart Rhythm Society 2013 Jun 10 (6): 849-55. Parvez Babar, Shoemaker M Benjamin, Muhammad Raafia, Richardson Rachael, Jiang Lan, Blair Marcia A, Roden Dan M, Darbar Dawo |
| Methylation markers for prostate cancer prognosis: a systematic review. Cancer causes & control : CCC 2013 6 24 (9): 1615-41. Chao Chun, Chi Margaret, Preciado Melissa, Black Mary Hel |
| Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. Journal of the American College of Cardiology 2012 Aug 60 (6): 539-45. Parvez Babar, Vaglio Joseph, Rowan Shane, Muhammad Raafia, Kucera Gayle, Stubblefield Tanya, Carter Shannon, Roden Dan, Darbar Dawo |
| Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy. The Journal of molecular diagnostics : JMD 2012 12 15 (2): 270-9. Dietrich Dimo, Hasinger Oliver, Bañez Lionel L, Sun Leon, van Leenders Geert J, Wheeler Thomas M, Bangma Chris H, Wernert Nicolas, Perner Sven, Freedland Stephen J, Corman John M, Ittmann Michael M, Lark Amy L, Madden John F, Hartmann Arndt, Schatz Philipp, Kristiansen Gl |
| Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. Journal of the American College of Cardiology 2010 Feb 55 (8): 747-53. Husser Daniela, Adams Volker, Piorkowski Christopher, Hindricks Gerhard, Bollmann Andre |
| Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation. The Journal of molecular diagnostics : JMD 2010 3 12 (3): 345-53. Schatz Philipp, Dietrich Dimo, Koenig Thomas, Burger Matthias, Lukas Antje, Fuhrmann Ina, Kristiansen Glen, Stoehr Robert, Schuster Matthias, Lesche Ralf, Weiss Gunter, Corman John, Hartmann Arn |
| DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 1 15 (1): 315-23. Hartmann Oliver, Spyratos Frédérique, Harbeck Nadia, Dietrich Dimo, Fassbender Anne, Schmitt Manfred, Eppenberger-Castori Serenella, Vuaroqueaux Vincent, Lerebours Florence, Welzel Katrin, Maier Sabine, Plum Achim, Niemann Stephan, Foekens John A, Lesche Ralf, Martens John W |
| DNA methylation of the PITX2 gene promoter region is a strong independent prognostic marker of biochemical recurrence in patients with prostate cancer after radical prostatectomy. The Journal of urology 2009 2 181 (4): 1678-85. Weiss Gunter, Cottrell Susan, Distler Jürgen, Schatz Philipp, Kristiansen Glen, Ittmann Michael, Haefliger Carolina, Lesche Ralf, Hartmann Arndt, Corman John, Wheeler Thom |
| Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer investigation 2009 2 27 (5): 549-60. Vanaja Donkena Krishna, Ehrich Mathias, Van den Boom Dirk, Cheville John C, Karnes R Jeffrey, Tindall Donald J, Cantor Charles R, Young Charles Y |
| Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 8 26 (31): 5036-42. Harbeck Nadia, Nimmrich Inko, Hartmann Arndt, Ross Jeffrey S, Cufer Tanja, Grützmann Robert, Kristiansen Glen, Paradiso Angelo, Hartmann Oliver, Margossian Astrid, Martens John, Schwope Ina, Lukas Antje, Müller Volkmar, Milde-Langosch Karin, Nährig Jörg, Foekens John, Maier Sabine, Schmitt Manfred, Lesche Ra |
| DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients. Breast cancer research and treatment 2007 10 111 (3): 429-37. Nimmrich Inko, Sieuwerts Anieta M, Meijer-van Gelder Marion E, Schwope Ina, Bolt-de Vries Joan, Harbeck Nadia, Koenig Thomas, Hartmann Oliver, Kluth Antje, Dietrich Dimo, Magdolen Viktor, Portengen Henk, Look Maxime P, Klijn Jan G M, Lesche Ralf, Schmitt Manfred, Maier Sabine, Foekens John A, Martens John W |
| DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. European journal of cancer (Oxford, England : 1990) 2007 7 43 (11): 1679-86. Maier Sabine, Nimmrich Inko, Koenig Thomas, Eppenberger-Castori Serenella, Bohlmann Inga, Paradiso Angelo, Spyratos Frédérique, Thomssen Christoph, Mueller Volkmar, Nährig Jörg, Schittulli Francesco, Kates Ronald, Lesche Ralf, Schwope Ina, Kluth Antje, Marx Almuth, Martens John W M, Foekens John A, Schmitt Manfred, Harbeck Nadia, |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: